Fig. 2
From: Patient Clinical Outcomes in Standalone Versus a Combined Ophthalmology-rheumatology Uveitis Clinic
Comparison of the frequency and dosage of systemic immunosuppressive therapies used in patients between the initial combined visit and 6 months prior to and after the initial combined visits. (A) The frequency of patients at target dosage of systemic immunomodulatory therapy (IMT). Fisher’s exact test. * p <0.05. ** p <0.01. (B) The average of daily systemic corticosteroid dosage at the three visits. Paired Student’s T test. ns: not significant